Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome

Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Apr 5, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring how different factors related to assisted reproductive technologies (ART), like in vitro fertilization (IVF) and the use of fresh or frozen embryos, might affect the health outcomes of pregnancies. The researchers want to find out if pregnancies achieved through ART have a higher risk of issues such as small babies for their gestational age, preeclampsia (a pregnancy complication marked by high blood pressure), stillbirth, and certain placental problems. They will compare these outcomes between pregnancies that were conceived through ART and those that occurred naturally.

To participate in the study, women aged 18 and older need to be expecting a single baby or twins and have a live fetus between 11 to 13 weeks of pregnancy. Participants will provide information about their medical history and ART treatment and will undergo routine check-ups, including ultrasounds to monitor the baby's growth. The goal is to use this information to enhance understanding and improve care for those using fertility treatments, ultimately helping healthcare providers give better advice and support to expectant parents.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria
• • Singleton or multiple pregnancies
• • Live fetus between 11 weeks plus 0 days and 13 weeks plus 6 days of gestation
• • Exclusion Criteria
• • Known genetic anomalies diagnosed before or after birth
• • Major fetal defects diagnosed before or after birth, such as acrania, holoprosencephaly, megacystis, exomphalos, congenital heart defects